About M.I.Tech
M.I.Tech is a Healthcare company based in Suwon (South Korea) founded in 1991, and was acquired by Boston Scientific in June 2022. Stents with applications in Cardiovascular and Gastrointestinal disorders. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices.
Company details
M.I.Tech develops a range of stents with applications in Cardiovascular and Gastrointestinal disorders. Products developed by the company include Coolstent Esophageal Stent (esophageal stent with application in palliative treatment of esophageal stricture and trachea-esophageal fistula), Hanarostent Biliary Stent (used for palliative treatment of bile duct stricture caused by malignant tumors), Pyloric Duodenal Stent (indicated for the palliative treatment of pyloric or duodenal strictures caused by malignant tumors), Colonic Rectal Stent (indicated for the palliative treatment of pyloric or duodenal strictures caused by malignant tumors), Tracheobronchial stent (is indicated for application in palliative treatment of trachealbronchial stricture andor tracheoesophageal fistula caused by malignant and benign tumors), and GI accessories.
- Headquarters Suwon, South Korea
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website mitech.co.kr
- Acquired by Boston Scientific (Jun 2022)
- Investors
- Acquired byBoston Scientific
(Jun 2022)
Investors in M.I.Tech
M.I.Tech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Boston Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Wide range of medical devices | 1979 | bostonscientific.com | Marlborough, United States |
Investor details for M.I.Tech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of M.I.Tech
2 dated milestones of M.I.Tech across 31 years, from founding to its latest funding, stage changes and deals.
- Founded M.I.Tech is founded.
- Exit Acquired by Boston Scientific.
Web traffic of M.I.Tech
The website of M.I.Tech (mitech.co.kr) receives about 3.7K visits a month.
- Monthly visits3.7K
▲ 23.5% vs previous month
Websites whose visitors overlap most with M.I.Tech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| duomed.com | 100% | 52.1K | #630,859 | View details | |
cnpskin.com | cnpskin.com | 94% | #570,441 | – | |
shinetox.co.kr | shinetox.co.kr | 78% | #1,836,666 | – | |
allwhitelaser.com | allwhitelaser.com | 73% | #1,346,052 | – | |
chakom.org | chakom.org | 64% | #2,370,267 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for M.I.Tech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about M.I.Tech
Complete news archive for M.I.Tech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about M.I.Tech
M.I.Tech was founded in 1991.
M.I.Tech is headquartered in Suwon, South Korea. It is registered at Suwon, Gyeonggi, South Korea.
M.I.Tech develops a range of stents with applications in Cardiovascular and Gastrointestinal disorders. Products developed by the company include Coolstent Esophageal Stent (esophageal stent with application in palliative treatment of esophageal stricture and trachea-esophageal fistula), Hanarostent Biliary Stent (used for palliative treatment of bile duct stricture caused by malignant tumors), Pyloric Duodenal Stent (indicated for the palliative treatment of pyloric or duodenal strictures caused by malignant tumors), Colonic Rectal Stent (indicated for the palliative treatment of pyloric or duodenal strictures caused by malignant tumors), Tracheobronchial stent (is indicated for application in palliative treatment of trachealbronchial stricture andor tracheoesophageal fistula caused by malignant and benign tumors), and GI accessories.
M.I.Tech has 1 investor. Key investors include Boston Scientific.
Yes. M.I.Tech was acquired by Boston Scientific in June 2022.